<DOC>
	<DOCNO>NCT00006394</DOCNO>
	<brief_summary>OBJECTIVES : I . Compare whether bone tissue spine hip improve patient adult onset growth hormone deficiency treat growth hormone ( GH ) v placebo . II . Determine whether blood sample patient show evidence beneficial bone effect treatment GH . III . Compare quality life patient treat 2 regimen . IV . Determine side effect GH patient .</brief_summary>
	<brief_title>Randomized Study Growth Hormone Bone Mineral Density Patients With Adult Onset Growth Hormone Deficiency</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize , double blind , placebo control , multicenter study . Patients randomize 1 2 treatment arm . Arm I : Patients receive growth hormone subcutaneously ( SC ) daily 2 year . Arm II : Patients receive placebo SC daily 2 year . Quality life assess initial eligibility screening , within 1 month initial screening , 1 , 3 , 6 month study therapy .</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism , Pituitary</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Diagnosis adult onset growth hormone deficiency Patient Characteristics Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>disease-related problem/condition</keyword>
	<keyword>endocrine disorder</keyword>
	<keyword>growth hormone deficiency</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>quality life</keyword>
	<keyword>rare disease</keyword>
</DOC>